Hexarelin dosage and evidence
Written by Aaron CuhaReviewed Sep 2026
The short answer
Hexarelin is a strong lab-made peptide that makes the body release growth hormone. It is also studied for direct effects that may protect the heart.
Evidence grade for Hexarelin: Moderate. The rule: at least one finished study in people, and at least 100 people who took it. The sum on this page: 6 completed trials, 105 people given it. A grade counts how much has been done to people, not whether it works.
- People given it
- 105
- Human studies
- 6
- Found nothing
- 0
Dose
No human dose established
Amounts that circulate in forums and on vendor pages are not a human dose. Amounts that were given in studies sit in Human evidence on this page.
Commonly reported amounts, in mcg. No approved label.
Amounts commonly reported by people buying Hexarelin, recorded for this archive's reconstitution calculator, are 100 and 200 mcg. They are self-reports rather than trial doses, and this archive does not recommend any of them. No human dose has been established for Hexarelin.
| Reported amount | Where the number comes from |
|---|---|
| 100 mcg | Commonly reported, no published human dosing trial |
| 200 mcg | Commonly reported, no published human dosing trial |
7 effects reported, 4 unwanted, 3 wanted, by people using it, not a trial
Goal pages: Fat loss and metabolism, Hormones and growth hormone, Heart and circulation
In plain English
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
Hexarelin gives you a big burst of growth hormone from a shot. It is a strong one, stronger than ipamorelin. The catch is your body gets used to it fast, and it stops working as well. It is not an approved drug.
What people take it for
- A bigger growth hormone spike than ipamorelin or GHRP-2.
- Muscle and fat loss.
- Heart protection. There is animal work behind this claim.
- Short bursts before a show or a hard training block.
What studies in people showed
In 12 healthy people, a shot into a vein released about twice as much growth hormone as the body's own release signal. So yes, it is strong. Then the problem. 12 healthy older people took it twice a day for 16 weeks. By the end the growth hormone response had dropped by about half. It came back four weeks after they stopped. So it fades on you. On the heart. In rats it protected the heart from damage even with no growth hormone in the picture. Then a small human study in people with bad heart failure. One shot into a vein raised how much blood the heart pumped, in the people whose heart failure came from blocked arteries. It did nothing for the people with a stretched, weak heart. Small study, one dose. Nobody has tested it long term for the heart.
What people report
Reports, not study results
The good
- The biggest growth hormone hit of the GHRP family, and people say they feel it.
- Strength and pumps in the first couple of weeks.
- Less hunger than GHRP-6.
The bad
- It stops working within a few weeks. Forums say it fades faster than any other GHRP. The 16 week trial on this page agrees that it fades.
- Raises cortisol and prolactin more than the others, so people report anxiety, edginess and lower sex drive.
- Water retention and tingling or numb hands.
- Flushing and a sleepy, heavy feeling after the shot.
Where these come from: The fade over 16 weeks and the heart data are from the trials on this page. The cortisol and prolactin rise is on this page but not from a trial listed here. The anxiety, water, tingling and fastest fade reports are from r/Peptides and vendor side effect guides, which are not neutral.
My bottom line
The strongest of the old growth hormone shots, and the one that quits on you fastest. Twice a day for four months and half the effect was gone. I would not run something that stops working while it raises my stress hormone.
An opinion, not a finding. I am a coach, not a doctor.
What it has been measured to do
Measured in people
Goals Hexarelin has been tested for in people, biggest studies first. We count only what the studies on this page say, so the real numbers may be higher.
- Growth hormone and IGF-1112 people · 5 studies
- Losing fat specifically21 people · 1 study
- Heart attacks and strokesno headcount stated · 1 study
What people using it report
Real people telling you what happened to them. Nobody checked it, and the people who post are not a fair sample, so it cannot prove anything works. It is still the best guide on this page to what people actually do with Hexarelin, what they expect, and what goes wrong. The full account, including the negative reports, is below.
32 of the 36 indexed goals have no study of any kind behind Hexarelin
No study in people, animals or cells on this page reports a result for these. That does not prove Hexarelin does nothing for them. It does mean anything you have heard about Hexarelin and one of these did not come from a study cited here.
Show full evidence
What is Hexarelin?
Hexarelin is a strong lab-made peptide that makes the body release growth hormone. It is also studied for direct effects that may protect the heart.
Hexarelin is a lab-made chain of six amino acids, from the same family as GHRP-2 and GHRP-6. It makes the pituitary gland release growth hormone. In 12 healthy volunteers, hexarelin given into a vein released about twice as much growth hormone as GHRH, the body's own signal. The body gets used to it. When 12 healthy older people took it twice a day for 16 weeks, the growth hormone response fell by about half. It came back four weeks after they stopped. In a small study of people with badly weakened hearts, one drip made the heart pump more blood with each beat. That happened when the damage came from blocked arteries, but not when the heart muscle was enlarged for other reasons.
It also acts on the heart directly, through a protein called CD36. In animal hearts without CD36, that effect disappeared. It is not an approved drug.
How does Hexarelin work?
It switches on the ghrelin receptor on the pituitary gland, which releases growth hormone. It also binds a protein on the heart called CD36, which is thought to be behind its heart protecting effects.
What have studies in people found about Hexarelin?
Hexarelin was given to people in a string of small hormone studies in the 1990s. Almost all of them gave one dose and measured the hormones released, not any health result. The longest anyone took it was 16 weeks, in 12 people. That study found the growth hormone response fell by about half.
- Age: 60 people in four groups (12 young children, 12 short children in puberty, 20 young adults and 16 older people) each got one 2.0 mcg/kg dose into a vein. Young adults released about twice as much growth hormone as older people: 1,829.7 against 951.1 in the units used. The stress hormone signal ACTH went the other way, trending higher in older people.
- Body fat: 21 healthy older people, with a middle age of 68, got one 1.5 mcg/kg shot under the skin. The more body fat they had, the lower their growth hormone peak. Fat mass predicted the response better than anything else measured.
- Pituitary testing: 19 patients who might have pituitary disease were tested with hexarelin and with the old insulin test, which drives blood sugar down. Hexarelin pushed growth hormone much higher, 67.1 against 26.9 mU/L. The two tests agreed on growth hormone status in 18 of 19. Cortisol peaks were lower after hexarelin, and the authors concluded it is no use for testing the cortisol system.
- Heart function: 13 patients with a badly weakened heart pump (8 with an enlarged heart and 5 with damage from blocked arteries) got one dose into a vein. In the 5 with artery damage, the share of blood pumped per beat rose from 22.6% to 26.2%. In the 8 with enlarged hearts it barely moved, 16.7% to 17.7%. Growth hormone rose about the same in both groups.
- Repeated doses: 12 healthy older people injected it under the skin twice a day for 16 weeks. Their growth hormone response fell from 19.1 at the start to 13.1 at week 1, 12.3 at week 4 and 10.5 at week 16 (in mcg/L/hour). Four weeks after stopping it was back to 19.4, about where it began.
- Strength and route: 12 healthy young volunteers. A 1 mcg/kg dose into a vein released about twice as much growth hormone as the body's own releasing hormone, GHRH, at the same dose (3,175 against 1,544). Compared with a vein, a shot under the skin delivered 77.0% of the drug, a nasal spray 4.8% and a pill 0.3%.
- Other hormones: healthy men were given 0 to 1.0 mcg/kg into a vein. Growth hormone topped out at 140 mU/L. Prolactin, a milk hormone, rose to 180% above where it started. Cortisol, a stress hormone, went up about 40% at 0.5 mcg/kg. Hexarelin releases these other hormones at doses close to the ones that release growth hormone.
What this does not tell you: No human study of hexarelin has measured body fat, muscle, strength, injury healing, sleep, bone strength or any health result. Every study above is a hormone test, most with a single dose. The largest had 60 people. The only repeated-dose study ran 16 weeks in 12 people and found the growth hormone response roughly halved. So one-dose numbers do not describe what happens to someone injecting daily. Prolactin and cortisol rise at doses close to the growth hormone dose. That sets hexarelin apart from more targeted growth hormone boosters. The human heart evidence is one single-dose study in 13 patients, with no comparison group and no follow-up. And nothing has been published on the milligram doses sold as research chemicals. Those are far larger than the microgram-per-kilogram doses used in every study above.
What do people who took Hexarelin report?
This is what real people say happened to them, good and bad. Nobody measured it. A report cannot tell a real effect from the lift people get just from expecting it to work, from a diet or training change made at the same time, or from what was really in the vial. We still put it near the top. It is the next best thing to a study in people: what happens when real people use it, including what goes wrong.
- Discussed almost entirely by comparison rather than on its own, as the strongest of the growth hormone releasing peptides and the one with the worst side effect profile. Nearly every mention places it against ipamorelin, GHRP-2 and GHRP-6 rather than describing it in isolation.
- Doses people describe cluster around 100 mcg two or three times a day. The same posters describe sharply diminishing returns above that, with doubling or tripling a saturation dose reported as producing far less than a doubling or tripling of response.
- Raised cortisol, a stress hormone, and raised prolactin, a hormone that can cause breast changes, are the negatives named most consistently, and they are described as occurring even at ordinary doses rather than only at high ones. Lowered libido and breast tissue changes are named as the downstream worries that follow from the prolactin side of that.
- The body ceasing to respond is the other recurring negative. It is described as setting in after around two weeks of nonstop use regardless of how low the dose is kept. Taking days off is the usual response people describe, which makes continuous use uncommon in these accounts.
- Cardiac effects are raised by some posters as the reason they find it interesting at all, which puts the discussion in a different place from the body composition framing around the other peptides in this family.
- Almost nobody posts a clean individual log. Most of what exists is comparison and caution, so there is very little in the way of a described timeline, and there are correspondingly few reports either of it doing something or of it doing nothing. That absence is the shape of the discussion rather than a finding about the compound.
Sources: Threads and peptide comparison discussion on MESO-Rx at thinksteroids.com, ExcelMale, Steroidology and LongeCity, found by site-restricted search and read directly, September 2026. Nothing above is attributed to any specific post and no post is reproduced.
The state of the research
Hexarelin is not a case of a molecule nobody could patent and so nobody funded. It had a company behind it. It went through a real clinical programme in the 1990s, both as a diagnostic test and as a possible treatment, and then it was dropped. That difference matters. A dropped programme that got unwelcome answers is not the same as a question nobody asked. Hexarelin is the first kind.
You can read those answers in the studies themselves. Repeated dosing cut the growth hormone response by about 45% within 16 weeks. That undercuts long-term use at exactly the point a treatment would need to keep working. It releases prolactin and cortisol at doses close to those that release growth hormone. That is a side effect problem a more targeted drug does not have. Body fat blunts the response, so the people most likely to want it get the least from it. And as a pituitary test it worked for growth hormone but not for cortisol. That shrank its use to a job other, cheaper tests already did.
The heart story is where public claims run ahead of the record. In people, there is one single-dose study in 13 patients with badly weakened hearts. The pumping measure rose in the 5 whose damage came from blocked arteries. It did not change in the 8 with enlarged hearts. Twenty-four years later nobody has followed that up. The rest of the heart story comes from animals and lab work, and must not be mixed with the human result. In rodents, and in hearts studied outside the body, hexarelin binds a heart protein called CD36. It protects heart muscle when blood flow is cut off and then restored. It does this even in animals with the pituitary gland removed, so it does not depend on growth hormone. Hearts bred without CD36 do not get that protection. Meanwhile the drug is sold on growth hormone numbers from 1994, to buyers who mostly do not know the 16-week study exists.
The evidence, in charts
Fig. 1a · how many people
124people, across 5 studies in people cited here
| Study | People | Share |
|---|---|---|
| European Journal of Endocrinology 1997 | 60 | 48% |
| Clinical Endocrinology 1998 | 21 | 17% |
| Clinical Endocrinology 1999 | 19 | 15% |
| Journal of Clinical Endocrinology and Metabolism 1994 | 12 | 10% |
| Growth Hormone and IGF Research 1998 | 12 | 10% |
Counts are the number of people each study on this page says it signed up. That includes studies that only watched people and gave nobody the compound. 2 more studies in people give no headcount and are not counted here. Studies still signing people up are left out, and only studies cited on this page are counted.
Fig. 1b · evidence mix
7 of 9 sources here are studies in people. The rest are not.
- Study in people · done in people778%
- Animal study · done in animals222%
Counted from the list of sources on this page. It counts only what we cite, so there may be more studies out there. A review counts once, however many studies it sums up.
Fig. 2 · evidence over time
The studies cover 6 different years, 1994 to 2002, counted from the list of sources on this page. The newest source on file is from 2002, more than five years ago. Research on it may have gone quiet.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four countries shown. This is what the law says, not a verdict on the science. See Legal status below for the full text and any notes.
Fig. 4 · how much does what
Nobody has tested different amounts in people
This chart would show how the effect changes as the amount goes up. For this compound, nobody has measured that in people. So we leave it empty. We will not borrow an animal chart and pretend it works the same in people.
Fig. 5 · what the molecule is
- Kind of compound
- Peptide
- Molecule weight
- 887.0 Da
- Half-life
- About 55 minutesUltra-short, minutes
- Chain length
- None on file
No amino acid sequence is on file for Hexarelin, so none is drawn rather than guessed from a name.
The studies we cite
- Study in people1994Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man
Hexarelin releases growth hormone, and more of it than the body's own signalling hormone does. Twelve healthy volunteers were given it into a vein, under the skin, up the nose and by mouth. The vein route roughly doubled the growth hormone release compared with the natural hormone. More of it did more, and the effect repeated across all four routes. This is a measurement of a hormone in the blood over a few hours. Nobody was followed to see whether their health changed.
In 12 healthy volunteers, IV hexarelin released about twice as much GH as GHRH; response was dose-dependent and reproducible across routes.
- Study in people1998Does desensitization to hexarelin occur?
Keep taking hexarelin and it stops working as well. Twelve healthy older people took it twice a day for sixteen weeks. By the end, the growth hormone it released was roughly half what it had been at the start. The fade was partial rather than total, and the response came back four weeks after they stopped. Everyone here got the drug, so there is nothing to compare against. Twelve people is also too few to say how often this happens.
Twice-daily hexarelin for 16 weeks in 12 healthy elderly people cut the GH response by roughly half; attenuation was partial and reversed 4 weeks after stopping.
- Study in people2002GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy
A single dose helped one kind of failing heart and not the other. Patients with badly weakened hearts were given hexarelin into a vein. In those whose damage came from blocked arteries, the heart pumped out more blood with each beat. In those whose heart muscle was enlarged for other reasons, nothing changed. Both groups released the same growth hormone, so the heart effect was not the hormone. This was a small study of one dose, with nothing measured about how people felt.
Acute IV hexarelin raised ejection fraction in ischemic cardiomyopathy patients but not in dilated cardiomyopathy, despite similar GH release; small study.
- Study in people1996Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study
Hexarelin releases growth hormone, and it releases stress and milk hormones at almost the same doses. Healthy young men were given single doses into a vein. Growth hormone climbed to a ceiling of 140 mU/L. Prolactin rose to 180% above where it started, and needed slightly less drug to do it. Cortisol stepped up about 40% at the middle dose. These other hormones are not a high-dose problem. They move together with the one people want.
Healthy adult males given 0 to 1.0 mcg/kg intravenously: growth hormone plateaued at 140 mU/L (ED50 0.48 mcg/kg), prolactin at 180% above baseline (ED50 0.39 mcg/kg) and cortisol stepped up about 40% at 0.5 mcg/kg. The off-target hormones move at doses close to the growth hormone dose.
- Study in people1997The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations
The older you are, the less growth hormone hexarelin gets out of you. 60 people across four age groups each got a single dose into a vein. Young adults released nearly twice as much growth hormone as elderly people, 1,829.7 against 951.1 in the units used. The stress hormone response went the other way, trending higher in the older group. So the people most likely to buy this get the least of the wanted hormone and more of the unwanted one.
60 subjects across four age groups at 2.0 mcg/kg intravenously: growth hormone area under the curve 1,829.7 mcg per min per L in young adults versus 951.1 in the elderly, while the ACTH response trended higher in the elderly.
- Study in people1998The effect of body composition on hexarelin-induced growth hormone release in normal elderly subjects
Body fat blunts the response, so the heavier you are the less hexarelin does. 21 healthy elderly people each got a single shot under the skin. The more fat someone carried, the lower their growth hormone peak, and fat mass predicted the response better than anything else measured. Being male or female made no difference on its own. This was 21 people and a single dose, which is a small basis for any rule.
21 healthy elderly subjects given 1.5 mcg/kg subcutaneously: peak growth hormone correlated negatively with fat mass (r = -0.72, P = 0.0001), with fat mass the strongest single predictor of the response. Gender was not an independent variable.
- Study in people1999Hexarelin as a test of pituitary reserve in patients with pituitary disease
As a pituitary test hexarelin works for growth hormone and fails for cortisol. 19 patients were tested both with hexarelin and with the old method of driving blood sugar down with insulin. Hexarelin pushed growth hormone far higher, 67.1 against 26.9 mU/L, and the two tests agreed on whether growth hormone was normal in 18 of the 19 patients. Cortisol peaks were lower after hexarelin. The authors conclude it is no use for checking the stress hormone axis.
19 patients compared against insulin-induced hypoglycaemia: peak growth hormone 67.1 versus 26.9 mU/L, with agreement on growth hormone status in 18 of 19. The authors conclude hexarelin is not a useful test of ACTH and cortisol reserve.
- Animal study2002CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
In animal hearts, this study found that CD36 is the protein hexarelin binds to on the heart. In hearts without CD36, its effects on the heart's blood vessels disappeared.
Identified CD36 as the cardiac binding protein for hexarelin; its coronary effects were absent in CD36-null hearts.
- Animal study1999Growth hormone-independent cardioprotective effects of hexarelin in the rat
In rats with the pituitary gland removed, seven days of hexarelin protected the heart from damage when its blood flow was cut off and then restored. These rats could not make growth hormone, so the protection did not come from growth hormone.
Seven days of hexarelin prevented ischemia-reperfusion damage in hypophysectomized rats, showing a cardioprotective action not mediated by GH.
Where to buy Hexarelin
66 sellers list Hexarelin in our latest read. They are ranked by trust score, then by archive rating, then by certificate tier, then by the lowest price per milligram. Archive evidence is counted before source-backed. Each path is out of 4, and the two are not added. A higher price does not raise the score. The letter is the certificate chip. 3 of them have a published certificate that names Hexarelin.
Some seller links may pay this site when you buy through them. A payment never changes a seller's tier or rank, and no seller has a say in any page.
| Seller | Trust score | Vial sizes | From, per mg | Certificate for Hexarelin | Seller link |
|---|---|---|---|---|---|
| Alpha Peptides | 80 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg | $5.91 | None found for Hexarelin | View |
| National Science Labs | 80 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 2 mg, 5 mg, 10 mg | $6.90 | None found for Hexarelin | View |
| Nationwide Peptides | 80 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 2 mg, 5 mg, 10 mg | $6.90 | None found for Hexarelin | View |
| Eros Peptides | 80 StrongSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $8.00 | None found for Hexarelin | View |
| BioGenix Peptides | 75 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg | $8.40 | None found for Hexarelin | View |
| Core Peptides | 75 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg | $9.40 | None found for Hexarelin | View |
| ezPeps | 73 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 10 mg | $5.90 | None found for Hexarelin | View |
| General Peptides | 73 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 2 mg, 5 mg, 10 mg | $6.90 | None found for Hexarelin | View |
| American Peptide Research | 70 StrongSource-backed 4 of 4. Archive evidence 2 of 4.A | 5 mg | $15.8 | None found for Hexarelin | View |
| Cell Peptides | 70 StrongSource-backed 2 of 4. Archive evidence 1 of 4.B | 5 mg | $7.80 | None found for Hexarelin | View |
| Modern Research Peptides | 67 FairSource-backed 4 of 4. Archive evidence 4 of 4.LC | 2 mg | $14.0 | Lab-confirmed certificate, Freedom Diagnostics | View |
| NuLife Peptides | 67 FairSource-backed 3 of 4. Archive evidence 2 of 4.B | 5 mg | $8.00 | None found for Hexarelin | View |
| Elite Miami Peptides | 66 FairSource-backed 3 of 4. Archive evidence 1 of 4.B | 5 mg | $8.99 | None found for Hexarelin | View |
| Protide Health | 50 FairSource-backed 2 of 4. Archive evidence 1 of 4.C | 3 mg | $18.3 | None found for Hexarelin | View |
| Blank Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 3 of 4.A | 10 mg | $6.50 | Certificate, Horizon Analytical, Freedom Diagnostics | View |
| Spartan BioLabs | 49 WeakSource-backed 3 of 4. Archive evidence 3 of 4.A | 10 mg | $6.50 | None found for Hexarelin | View |
| Biotech Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 3 of 4.A | 5 mg | $9.80 | Certificate, MZ Biolabs | View |
| BioPep USA | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 10 mg | $7.00 | None found for Hexarelin | View |
| Core Peptides Official | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $8.00 | None found for Hexarelin | View |
| Luxe Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $8.00 | None found for Hexarelin | View |
| Research Purpose Labs | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $9.00 | None found for Hexarelin | View |
| Pentech Peptide | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $9.00 | None found for Hexarelin | View |
| Peptide Powerhouse | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 2 mg, 5 mg | $9.00 | None found for Hexarelin | View |
| Peptify Labs | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $12.0 | None found for Hexarelin | View |
| True Lab Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 3 mg | $12.7 | None found for Hexarelin | View |
| San Diego Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $13.0 | None found for Hexarelin | View |
| Triantex | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $16.0 | None found for Hexarelin | View |
| Molecular Edge Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 2 of 4.A | 5 mg | $20.0 | None found for Hexarelin | View |
| Cenexa Labs | 49 WeakSource-backed 2 of 4. Archive evidence 2 of 4.B | 2 mg, 5 mg | $9.00 | None found for Hexarelin | View |
| Pure Tested Peptides | 49 WeakSource-backed 3 of 4. Archive evidence 1 of 4.B | 5 mg | $13.8 | None found for Hexarelin | View |
| Enhanced Peptides | 49 WeakSource-backed 2 of 4. Archive evidence 1 of 4.B | 2 mg | $22.5 | None found for Hexarelin | View |
| Solution Peptides | 48 WeakSource-backed 1 of 4. Archive evidence 0 of 4.C | 5 mg | $8.00 | None found for Hexarelin | View |
| Melanotan Express | 46 WeakSource-backed 3 of 4. Archive evidence 1 of 4.B | 2 mg | $12.0 | None found for Hexarelin | View |
| Top Peptides | 45 WeakSource-backed 2 of 4. Archive evidence 1 of 4.C | 5 mg | $7.80 | None found for Hexarelin | View |
| Transforma Peptides | 43 WeakSource-backed 3 of 4. Archive evidence 1 of 4.B | 2 mg, 5 mg | $9.50 | None found for Hexarelin | View |
| Peptide Works | 43 WeakSource-backed 2 of 4. Archive evidence 1 of 4.B | 2 mg, 5 mg | $7.27 | None found for Hexarelin | View |
| Pryma Lab | 43 WeakSource-backed 1 of 4. Archive evidence 0 of 4.C | 2 mg, 5 mg | $7.60 | None found for Hexarelin | View |
| Atomik Labz | 43 WeakSource-backed 1 of 4. Archive evidence 0 of 4.C | 5 mg | $8.00 | None found for Hexarelin | View |
| Peptides.com | 42 WeakSource-backed 2 of 4. Archive evidence 2 of 4.B | 5 mg | $7.20 | None found for Hexarelin | View |
| Direct SARMS | 40 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 2 mg, 5 mg | $7.29 | None found for Hexarelin | View |
| Peptide Pros | 39 WeakSource-backed 4 of 4. Archive evidence 1 of 4.B | 2 mg | $12.0 | None found for Hexarelin | View |
| Limitless Biotech ST | 36 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 2 mg, 5 mg, 10 mg | $6.90 | None found for Hexarelin | View |
| Evolution Peptides USA | 36 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $7.00 | None found for Hexarelin | View |
| Aries Peptide Research | 36 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg, 10 mg, 15 mg | $11.0 | None found for Hexarelin | View |
| Valar Peptides | 35 WeakSource-backed 2 of 4. Archive evidence 1 of 4.B | 5 mg | $7.40 | None found for Hexarelin | View |
| Lejian Biotech Peptide | 35 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $8.00 | None found for Hexarelin | View |
| Republic Peptide | 33 WeakSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $9.00 | None found for Hexarelin | View |
| Paramount Peptides | 33 WeakSource-backed 1 of 4. Archive evidence 0 of 4.C | 5 mg | $13.6 | None found for Hexarelin | View |
| LabRat Peptides | 28 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 10 mg | $6.00 | None found for Hexarelin | View |
| Domi Peptides | 28 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $8.40 | None found for Hexarelin | View |
| Peptide Producer | 28 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $8.80 | None found for Hexarelin | View |
| Peptides Sales | 28 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 2 mg | $10.0 | None found for Hexarelin | View |
| Huaian Hanyou Peptide | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $8.00 | None found for Hexarelin | View |
| MJA Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $8.00 | None found for Hexarelin | View |
| ZL Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 5 mg | $8.00 | None found for Hexarelin | View |
| Peptide Science LLC | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 2 mg, 5 mg | $9.00 | None found for Hexarelin | View |
| USA Peptide Sciences | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 2 mg, 5 mg | $9.00 | None found for Hexarelin | View |
| Ascend Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 1 of 4.C | 2 mg, 5 mg, 10 mg | $17.7 | None found for Hexarelin | View |
| Elutide | 25 InsufficientSource-backed 1 of 4. Archive evidence 0 of 4.C | 10 mg | $5.90 | None found for Hexarelin | View |
| Pure Health Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 0 of 4.C | 5 mg, 10 mg | $6.40 | None found for Hexarelin | View |
| Pharma Grade Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 0 of 4.C | 10 mg | $8.00 | None found for Hexarelin | View |
| Grey Research Peptides | 25 InsufficientSource-backed 1 of 4. Archive evidence 0 of 4.C | 5 mg | $10.0 | None found for Hexarelin | View |
| AMC Essentials | 16 InsufficientSource-backed 1 of 4. Archive evidence 0 of 4.Letter withheld | 5 mg | $6.60 | None found for Hexarelin | View |
| Tydes | 15 InsufficientSource-backed 1 of 4. Archive evidence 0 of 4.Letter withheld | 6 mg | $7.50 | None found for Hexarelin | View |
| Skye Peptides | 0 InsufficientSource-backed 3 of 4. Archive evidence 1 of 4.Letter withheld | 5 mg | $8.80 | None found for Hexarelin | View |
| Biostrategix | 0 InsufficientSource-backed 3 of 4. Archive evidence 0 of 4.Letter withheld | 5 mg | $7.00 | None found for Hexarelin | View |
- LC Lab-confirmed: the issuing laboratory echoed this certificate back
- A Current certificate, independent laboratory named, laboratory not yet checked
- B Certificate published, but no laboratory link, older than a year, or the laboratory did not recognise the published lookup
- C No certificate could be read
Every listing and vial size for Hexarelin · How the trust score is counted
Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.
Common questions
Has Hexarelin been tested in people?
Yes. 105 people given it across 6 completed trials cited here, 0 of which found nothing. Hexarelin is a strong lab-made peptide that makes the body release growth hormone. It is also studied for direct effects that may protect the heart.
What is the Hexarelin dosage?
No human dose established. Amounts that circulate in forums and on vendor pages are not a human dose. Amounts that were given in studies sit in Human evidence on this page. Commonly reported amounts, in mcg. No approved label.
Is Hexarelin FDA-approved?
Not FDA-approved
How is hexarelin different from ipamorelin?
Hexarelin is stronger at releasing growth hormone but less targeted. It can raise cortisol and prolactin, and the body gets used to it with repeated use. Ipamorelin is more targeted.